|
Status |
Public on Apr 25, 2022 |
Title |
RNA polymerase II (RNAPII) ChIP-seq analysis evaluating effects of Cdk7 inhibitor THZ1 on responses of neonatal rat ventricular myocytes (NRVM) to adrenergic receptor agonist phenylephrine (PE) |
Organism |
Rattus norvegicus |
Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
|
Summary |
RNA polymerase II (RNAPII) ChIP-seq analysis evaluating effects of Cdk7 inhibitor THZ1 on responses of NRVM to adrenergic receptor agonist PE
|
|
|
Overall design |
Profiles of NRVM RNAPII occupancies from three groups: 1. Vehicle; 2. PE (100 μM); 3. PE (100 μM)+THZ1(10 nM);
|
|
|
Contributor(s) |
Duan Q, Day D |
Citation(s) |
35896549 |
|
Submission date |
May 27, 2020 |
Last update date |
Jul 29, 2022 |
Contact name |
Saptarsi Haldar |
E-mail(s) |
shalda01@amgen.com
|
Organization name |
Amgen
|
Street address |
1120 Veterans Blvd
|
City |
South San Francisco |
State/province |
CA |
ZIP/Postal code |
94080 |
Country |
USA |
|
|
Platforms (1) |
GPL18694 |
Illumina HiSeq 2500 (Rattus norvegicus) |
|
Samples (6)
|
|
Relations |
BioProject |
PRJNA635293 |
SRA |
SRP264911 |